Cetera Investment Advisers
FLNA

Cetera Investment Advisers’s Filana Therapeutics FLNA Stock Holding History

Cetera Investment Advisers’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Buy
15,242
+776
+5% +$1.11K ﹤0.01% 4861
2026
Q1 		$24.4K Sell
14,466
-2,423
-14% -$4.99K ﹤0.01% 4645
2025
Q4 		$33.4K Buy
16,889
+126
+0.8% +$403 ﹤0.01% 4547
2025
Q3 		$48.8K Buy
16,763
+2,758
+20% +$6.34K ﹤0.01% 4431
2025
Q2 		$25.3K Buy
14,005
+304
+2% +$541 ﹤0.01% 4012
2025
Q1 		$20.6K Buy
13,701
+1,553
+13% +$3.92K ﹤0.01% 3912
2024
Q4 		$28.7K Sell
12,148
-30,406
-71% -$534K ﹤0.01% 3693
2024
Q3 		$1.25M Buy
42,554
+4,664
+12% +$107K ﹤0.01% 1958
2024
Q2 		$468K Buy
37,890
+18,108
+92% +$382K ﹤0.01% 2647
2024
Q1 		$401K Buy
+19,782
New +$456K ﹤0.01% 2786

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Cetera Investment Advisers's FLNA Position: Q2 2026 in Review

Cetera Investment Advisers increased its Filana Therapeutics (FLNA) stake by 5.4% in Q2 2026, buying an estimated $1.11K and bringing the position to 15,242 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4861.

Cetera Investment Advisers first reported a position in FLNA in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.25M in Q3 2024. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Cetera Investment Advisers held 15,242 shares of Filana Therapeutics worth $18.1K as of Q2 2026.
  • Cetera Investment Advisers bought 776 Filana Therapeutics shares in Q2 2026, an estimated $1.11K.
  • Filana Therapeutics made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4861 holding.
  • Cetera Investment Advisers first reported a position in Filana Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Cetera Investment Advisers's Filana Therapeutics position peaked at $1.25M in Q3 2024.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.